FIELD: biotechnology.
SUBSTANCE: invention is a recombinant plasmid DNA pET3.54, encoding the polypeptide FN3.54, interacting with human tumour necrosis factor. The present invention also discloses the recombinant strain of bacteria Escherichia coli BL21(DE3)/pET3.54 - producer of the polypeptide FN3.54, interacting with human tumour necrosis factor.
EFFECT: invention enables to obtain the desired protein with high yield, using a smaller amount of the inducer and the expression level of total cell protein.
2 cl, 4 dwg, 6 ex
Authors
Dates
2014-10-20—Published
2013-03-04—Filed